Artwork

Content provided by Nancy Donohoo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nancy Donohoo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

05: Roger Longman on the Drug Pricing War

33:50
 
Share
 

Manage episode 162630870 series 1042267
Content provided by Nancy Donohoo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nancy Donohoo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Don’t miss my discussion with Roger Longman, CEO of Real Endpoints, as we dive into the hotly contested issue of drug pricing in America. You’ll understand why Fortune Magazine named Roger to the drug pricing “Dream Team” (March, 2016 issue) as someone who could help fix the problem.

You’ll hear Roger’s insights on the following:

  • Is it fair to point the finger at the drug makers for the unsustainable pricing of prescription drugs today?

  • What should pharma and biotech companies being doing differently given the current climate?

  • What can payers and PBMs be doing differently?

  • What kind of talent is needed in the pharma and payer sectors?

  • Why the big focus on orphan and specialty drugs. Don’t we need more focus on common chronic illnesses, such as diabetes?

  • What is the future of outcomes-based reimbursement?

  • Learn how Real Endpoints helps payers and pharma companies to be more savvy in dealing with today’s unpredictable environment.
  continue reading

7 episodes

Artwork
iconShare
 
Manage episode 162630870 series 1042267
Content provided by Nancy Donohoo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nancy Donohoo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Don’t miss my discussion with Roger Longman, CEO of Real Endpoints, as we dive into the hotly contested issue of drug pricing in America. You’ll understand why Fortune Magazine named Roger to the drug pricing “Dream Team” (March, 2016 issue) as someone who could help fix the problem.

You’ll hear Roger’s insights on the following:

  • Is it fair to point the finger at the drug makers for the unsustainable pricing of prescription drugs today?

  • What should pharma and biotech companies being doing differently given the current climate?

  • What can payers and PBMs be doing differently?

  • What kind of talent is needed in the pharma and payer sectors?

  • Why the big focus on orphan and specialty drugs. Don’t we need more focus on common chronic illnesses, such as diabetes?

  • What is the future of outcomes-based reimbursement?

  • Learn how Real Endpoints helps payers and pharma companies to be more savvy in dealing with today’s unpredictable environment.
  continue reading

7 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide